News

The current collaboration follows previous agreements, initially started in 2004, and extends the partnership between both the two parties for three years. The tie up will provide support

The clinical study is being directed by Steffen Weikert, assistant director of the clinic for Urology at the Charite of Berlin. The primary goal of this study is

SurModics said that Maharaj will also serve as a member of SurModics’ board of directors. Maharaj, who most recently served as president and CEO of Arizant, will replace

SurModics Pharmaceuticals, which was formed following the acquisition of Brookwood Pharmaceuticals in July 2007, is a product-focused player in drug delivery, providing a range of technology solutions to

The agreement is part of UCB‘s strategy to optimise its manufacturing network in line with the evolution of its portfolio and includes the manufacturing sites of Monheim and

Alcon‘s board of directors approved a merger agreement with Novartis. Under the terms of the agreement, the merger consideration will include up to 2.8 Novartis shares and a

The main focus of Bayer HealthCare is on antibodies, coagulation factors and other therapeutic proteins. According to Bayer the building will be a multipurpose facility with great flexibility,

The study will investigate the safety and efficacy of Bepotastine besilate, dosed twice daily, in patients presenting with allergic rhinitis caused by one of the most potent seasonal

The trial will evaluate PSI-7977 400mg QD in combination with ribavirin (RBV), with 0, 4, 8, or 12 weeks of pegylated interferon alfa 2a (Peg-IFN) in treatment-naive patients